Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of RBL2 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of RBL2 mRNA | affects expression | 21346803
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of RBL2 mRNA | increases expression | 16788091
|
C026137 |
3-hydroxyacetanilide |
3-hydroxyacetanilide results in decreased expression of RBL2 mRNA | decreases expression | 18544908
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of RBL2 mRNA | decreases expression | 12419474
|
C107875 |
6-(methylamino)pyrido(3,4-d)pyrimidine |
6-(methylamino)pyrido(3,4-d)pyrimidine results in increased expression of RBL2 protein | increases expression | 15572027
|
D000082 |
Acetaminophen |
Acetaminophen results in decreased expression of RBL2 mRNA | decreases expression | 18544908
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of RBL2 mRNA | affects expression | 16483693
|
D001149 |
Arsenates |
[Atrazine co-treated with Arsenates] results in increased expression of RBL2 mRNA | affects cotreatment|increases expression | 18585445
|
D001280 |
Atrazine |
[Atrazine co-treated with Arsenates] results in increased expression of RBL2 mRNA | affects cotreatment|increases expression | 18585445
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of RBL2 mRNA | decreases expression | 12419474
|
D002087 |
Butyrates |
Butyrates results in decreased expression of RBL2 mRNA | decreases expression | 14674679
|
C031938 |
calmidazolium |
calmidazolium results in decreased phosphorylation of RBL2 protein | decreases phosphorylation | 15708436
|
C059041 |
calyculin A |
calyculin A inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL2 protein] | decreases phosphorylation|decreases reaction | 12621062
|
D002166 |
Camptothecin |
RBL2 protein inhibits the reaction [Camptothecin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15585644
|
D002166 |
Camptothecin |
RBL2 protein results in decreased susceptibility to Camptothecin | decreases response to substance | 15585644
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of RBL2 protein | decreases expression | 19887370
|
C099555 |
CD 437 |
CD 437 results in increased expression of RBL2 protein | increases expression | 15059897
|
C098869 |
clasto-lactacystin beta-lactone |
clasto-lactacystin beta-lactone results in increased expression of RBL2 protein | increases expression | 16936753
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of RBL2 mRNA | decreases expression | 20106945
|
D019259 |
Lamivudine |
[Zidovudine co-treated with Lamivudine] results in decreased expression of RBL2 mRNA | affects cotreatment|decreases expression | 15784690
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of RBL2 mRNA | decreases expression | 18042831
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of RBL2 protein | increases expression | 19887370
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of RBL2 mRNA | increases expression | 14729647
|
D004112 |
Dimercaprol |
Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of RBL2 mRNA] | decreases expression|decreases reaction | 16377760
|
D004317 |
Doxorubicin |
Doxorubicin promotes the reaction [RBL2 protein binds to CCNA2 promoter] | affects binding|increases reaction | 16537896
|
D004317 |
Doxorubicin |
Doxorubicin promotes the reaction [RBL2 protein binds to CCNB1 promoter] | affects binding|increases reaction | 16537896
|
D004317 |
Doxorubicin |
Doxorubicin promotes the reaction [RBL2 protein binds to CDK1 promoter] | affects binding|increases reaction | 16537896
|
D004317 |
Doxorubicin |
Doxorubicin promotes the reaction [RBL2 protein binds to PCNA promoter] | affects binding|increases reaction | 16537896
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of RBL2 protein | increases expression | 16537896
|
D004317 |
Doxorubicin |
RBL2 protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 15585644
|
D004317 |
Doxorubicin |
RBL2 protein inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] | decreases reaction|increases phosphorylation | 15585644
|
D004317 |
Doxorubicin |
RBL2 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 15585644
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of RBL2 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in decreased expression of RBL2 mRNA | decreases expression | 19619570
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of RBL2 mRNA | decreases expression | 18035473
|
C040313 |
fostriecin |
fostriecin results in increased phosphorylation of RBL2 protein | increases phosphorylation | 16936753
|
C096856 |
FTI 277 |
[Tamoxifen co-treated with FTI 277] results in decreased phosphorylation of RBL2 protein | affects cotreatment|decreases phosphorylation | 12866041
|
D017313 |
Fenretinide |
Fenretinide results in increased expression of RBL2 protein | increases expression | 15059897
|
D006861 |
Hydrogen Peroxide |
calyculin A inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL2 protein] | decreases phosphorylation|decreases reaction | 12621062
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of RBL2 mRNA | decreases expression | 12419474
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased phosphorylation of RBL2 protein | decreases phosphorylation | 12621062
|
D006861 |
Hydrogen Peroxide |
Okadaic Acid inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL2 protein] | decreases phosphorylation|decreases reaction | 12621062
|
D009151 |
Mustard Gas |
Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of RBL2 mRNA] | decreases expression|decreases reaction | 16377760
|
D009151 |
Mustard Gas |
Mustard Gas results in decreased expression of RBL2 mRNA | decreases expression | 16377760
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of RBL2 mRNA | increases expression | 15674843
|
D019319 |
Okadaic Acid |
Okadaic Acid inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL2 protein] | decreases phosphorylation|decreases reaction | 12621062
|
D019319 |
Okadaic Acid |
Okadaic Acid results in increased phosphorylation of RBL2 protein | increases phosphorylation | 16936753
|
D010126 |
Ozone |
Ozone results in decreased expression of RBL2 mRNA | decreases expression | 16330353
|
C041786 |
palm oil |
palm oil results in decreased expression of RBL2 mRNA | decreases expression | 18042831
|
C035988 |
procymidone |
procymidone results in increased expression of RBL2 mRNA | increases expression | 15686871
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of RBL2 mRNA | affects expression | 19822182
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with FTI 277] results in decreased phosphorylation of RBL2 protein | affects cotreatment|decreases phosphorylation | 12866041
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of RBL2 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of RBL2 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of RBL2 mRNA | decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of RBL2 mRNA | increases expression | 16102516
|
D014212 |
Tretinoin |
RBL2 protein affects the susceptibility to Tretinoin | affects response to substance | 16206244
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [PPP2CA protein binds to RBL2 protein] | affects binding|increases reaction | 16206244
|
D014212 |
Tretinoin |
Tretinoin results in decreased ubiquitination of RBL2 protein | decreases ubiquitination | 16936753
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of RBL2 protein | increases expression | 15059897
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [PPP2CA protein binds to and results in decreased phosphorylation of RBL2 protein] | affects binding|decreases phosphorylation|increases reaction | 16936753
|
D014212 |
Tretinoin |
Tretinoin results in increased stability of and results in increased expression of RBL2 protein | increases expression|increases stability | 16936753
|
D015215 |
Zidovudine |
[Zidovudine co-treated with Lamivudine] results in decreased expression of RBL2 mRNA | affects cotreatment|decreases expression | 15784690
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.10 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.41 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.12 | 18287403 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.39 | 9612607 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
6.49 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
6.49 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
6.49 | 10697514 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.59 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
8.58 | 16434500 19061943 17162532 17620307 18056438 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.58 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.25 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.45 | 16712894 17306315 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
3.79 | 11874814 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.12 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.26 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.34 | 15513908 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.82 | 10965797 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.57 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.39 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.46 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
2.80 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.26 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.26 | 16292516 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
7.05 | 10378619 |
MESH:D001249 |
Asthma |
|
Ozone |
7.05 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Tretinoin |
7.05 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.47 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.98 | 16935849 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.72 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.63 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
7.63 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.34 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.47 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.25 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
7.85 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
7.85 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
5.30 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
5.30 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
5.30 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
5.30 | 15993339 16595493 16264153 17369602 15136595 15634643 16096432 15668708 19526202 18628466 16826403 17983394 15692762 17426702 16322301 18234424 18382427 15567936 15994142 11325840 15939500 16115903 18695136 16935488 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
5.30 | 12948864 17261762 17289903 19861407 16675129 18497071 14630087 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
5.30 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
5.30 | 19244106 18855134 19410462 16873071 18629630 17893378 18425577 21152245 20065188 18815881 11161223 18351453 17049068 17440819 19487384 19200415 16273361 19189212 17242785 19115204 16818667 19221464 19059307 19142967 17261762 19011961 19288272 16202921 19289846 19189210 21138602 19084267 18997820 15565566 20135344 20544844 19066611 15668708 20390343 19103187 19155303 18984771 20005174 20859285 18821012 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.30 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
5.30 | 16873071 16443354 16166294 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.33 | 14754758 18315731 17626835 15516495 16777450 18417511 19059883 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.72 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.53 | 10378619 17687719 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.15 | 16813970 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.30 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.02 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.35 | 18705752 16227642 16097048 15673190 10355542 16192424 16011737 15700767 16124888 3786805 15721981 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.36 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.45 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.07 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.71 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
24.05 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
24.05 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
24.05 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
24.05 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
24.05 | 16681979 17138121 16807293 20514400 19394651 20727157 18494052 19052882 18785209 19539802 20935162 3084413 16540662 16288022 16830150 11831363 20101231 18506893 17428255 21159647 10737359 18210153 19418558 16502159 18056438 20524982 10672840 16328049 19919837 17173139 19208518 17978847 3581430 16779866 18665156 16878318 19335982 18393292 19519916 19822196 19107877 16569478 18978308 17761372 20432363 19701751 16698587 20214788 18691550 19171122 17055752 16935385 20084675 18788625 18971187 20007298 20512989 19383236 17162532 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
24.05 | 16234567 17876044 18059187 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
24.05 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
24.05 | 16270382 17159502 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
24.05 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
24.05 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
24.05 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
2.94 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
12.77 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
12.77 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
12.77 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
12.77 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
12.77 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.23 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.11 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.23 | 16364871 17924179 17007740 17974986 15792986 16269455 16952015 15476868 16278810 16651473 16612575 17519947 17382496 15505089 17131338 16731534 15811867 17928571 16242529 17351982 17329180 16109756 16455267 18627295 17308081 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.78 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.21 | 16936243 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.33 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.33 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
17.81 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
17.81 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
17.81 | 17174075 7505956 2727394 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
17.81 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
17.81 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
11.50 | 16154183 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
11.50 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.09 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.09 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.59 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.71 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.10 | 12621046 8697196 15668235 16354765 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.10 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.28 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Butyrates |
3.00 | 15936596 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.78 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
2.78 | 17273769 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.69 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.29 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.29 | 9142499 16925845 8800419 17551590 10589399 9211117 9664655 14991402 9125849 9224671 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
9.46 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
9.46 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.93 | 19031437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
3.80 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
3.80 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.61 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
7.61 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
16.34 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
16.34 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
16.34 | 11739529 18071297 16393943 17906064 11743745 16781746 15968718 19739265 11421492 11461765 12540782 14725611 17522070 10915739 19923254 16109766 19085960 18713872 2444490 19416960 19164858 12705907 12594235 16177239 15619225 11287661 17562736 10663392 14986274 12153990 14550746 16081117 11529661 19420014 16227642 19370779 16485898 11834606 12392966 12958197 10774834 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
16.34 | 2869522 7179309 11566570 6623471 16227642 10915739 16177239 6884620 7440962 10092053 17522070 21278145 9327722 3732212 15968718 19336974 19085960 15027814 4309450 7120509 15998439 3786805 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
16.34 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
16.34 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
16.34 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.65 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
16.96 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Lamivudine |
16.96 | 15040536 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
16.96 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
16.96 | 15040536 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.13 | 18367378 |
MESH:D004487 |
Edema |
|
Mustard Gas |
5.56 | 11402378 9260866 11428631 11428647 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.56 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.44 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.44 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
7.83 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
7.83 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
15.35 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
15.35 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
15.35 | 19155303 20544844 16202921 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
15.35 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.64 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.70 | 18037988 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.72 | 9357497 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.66 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.73 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.73 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
25.60 | 16045604 12631006 61145 15959796 19224547 17595544 12795759 16239168 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
25.60 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
25.60 | 19551842 18296743 19004024 17967931 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
25.60 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
25.60 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
25.60 | 18299183 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.96 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.02 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.08 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
9.97 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
9.97 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
23.14 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
23.14 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
23.14 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
23.14 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
23.14 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.22 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.24 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.78 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
14.64 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
14.64 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Okadaic Acid |
14.64 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
14.64 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.14 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
6.83 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
6.83 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.71 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.72 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.72 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.18 | 16495754 12587719 18006777 16879835 16244372 16144979 17875725 14766674 18674790 16707910 16244371 17888722 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.07 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.51 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.30 | 12579204 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.98 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.94 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.18 | 19900420 19110552 |
MESH:D006509 |
Hepatitis B |
|
Lamivudine |
4.70 | 17703166 |
MESH:D019694 |
Hepatitis B, Chronic |
|
Lamivudine |
4.70 | 15631357 15274664 12044531 15309715 16476009 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.58 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Lamivudine |
6.25 | 11141242 20032539 9296927 17530837 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
6.25 | 11698656 11141242 11363243 20032539 17358032 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.29 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
6.26 | 18501091 17606976 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.26 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.30 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.59 | 16354765 15340226 18606429 8697196 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.47 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.47 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.09 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.20 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.14 | 16778211 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.21 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.33 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.33 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.66 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
6.10 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.10 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
16.80 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
16.80 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
16.80 | 17296493 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
16.80 | 9357497 11428620 17524151 8975870 9260866 16001271 11402378 11428647 11428631 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
16.80 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
16.80 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
6.39 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.39 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.34 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.62 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.62 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.99 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
16.23 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
16.23 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
16.23 | 16775033 15699352 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
16.23 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
16.23 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
8.81 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
8.81 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
24.45 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
24.45 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
24.45 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
24.45 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
24.45 | 18625569 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
24.45 | 12579204 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.54 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.70 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
marker/mechanism |
|
| 16038780 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.02 | 20370541 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.30 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.00 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.86 | 17301526 9834237 17294898 19029980 19642359 16140955 16788101 12679006 16823087 16331271 17649720 17368321 16935935 15748426 17339181 17506722 17361223 17217047 17107899 16766008 16891316 17712046 19075265 19225113 19035177 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.59 | 16707609 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.99 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.84 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
9.53 | 11408273 16221502 17334410 16943688 21278145 11903743 16239168 17174718 17157831 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
9.53 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
9.53 | 18665156 20032147 19638242 18522880 18407596 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
7.85 | 18481824 17976157 15362042 14716496 17944888 17481882 17766677 17714472 16116963 18376398 11481614 17922224 12958196 18251166 17721639 12649538 17525996 12445418 15893842 15931870 15876570 18395914 12445421 16638106 15057751 16033810 17708605 16011737 17565644 16015684 12632512 18277467 12741479 12546737 16192424 15959796 16027843 18412020 18339082 18263696 15650968 18054572 15730626 18472094 15996030 16097048 18210741 17869086 12667390 16136751 15673190 17900296 14724832 15818738 18418968 12898905 16248980 18006644 18166357 14620537 18705752 18472332 15123356 15925388 10355542 15052691 18156304 14748882 18317297 17557913 17761835 17698563 18187930 12389079 17640975 12609069 12632514 18395095 18205269 12666154 18429990 17823541 12586293 14716833 18279442 14512876 17631135 15370692 15338365 18420326 20821823 17805973 13678700 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
7.85 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
7.85 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
7.85 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
7.85 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
7.85 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
5.69 | 19014921 16611625 19784758 12969438 11587558 16610002 12587719 19460945 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
5.69 | 17285989 15720792 16964402 16246199 15830285 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
5.69 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.73 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.13 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.13 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
15.56 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
15.56 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
15.56 | 21047994 19690152 20118626 19638242 19256749 18754104 20583210 18644402 19833225 19073162 19255062 19426721 9163691 21278145 19254457 20137499 2862719 12112319 20492335 18977376 2422723 19499222 21167192 16942905 18978307 20452335 20434301 12771043 15885732 19294768 21071580 19427195 19996281 19812893 19551842 19090486 19642983 20501860 15175105 20101389 18648771 19850985 10737359 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
15.56 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
15.56 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
15.56 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
15.63 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
15.63 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
15.63 | 18775883 19004024 19539802 17942915 18253720 19519916 18093689 18282651 18164116 16842330 19126423 9362446 18079962 17854601 16267830 18308698 19009564 2563599 18544905 17174075 3124819 21159647 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
15.63 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
15.63 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
10.65 | 18161513 18702808 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
10.65 | 8266340 19066396 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
10.65 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.42 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
11.79 | 20512841 21163286 6695378 20970405 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
11.79 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
11.79 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
11.79 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
11.79 | 15276417 17077188 17306315 16712894 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
11.79 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
11.79 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
11.79 | 18800350 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.14 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.43 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.13 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.32 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
11.92 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
11.92 | 16891317 11807958 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
11.92 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
11.92 | 14580682 19196723 11731420 16827153 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.14 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.14 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.60 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
8.78 | 16827129 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
8.78 | 16270382 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
8.78 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
8.78 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
8.78 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.74 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.14 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.99 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
5.92 | 1916698 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
5.92 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.34 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.65 | 10496685 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
5.39 | 17358032 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.10 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
3.98 | 16274795 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.35 | 17415656 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.82 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.76 | 19429709 15857846 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.67 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
2.94 | 16810080 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
8.87 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
8.87 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
8.40 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.40 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
8.40 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.36 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
7.07 | 15958647 17353921 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
7.07 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
7.07 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.24 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.55 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.29 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.34 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.99 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
8.06 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
8.06 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
13.90 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
13.90 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
13.90 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.33 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.33 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.02 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
6.99 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
6.99 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.66 | 20387270 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.23 | 16303764 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.57 | 16761898 7688884 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.17 | 11836018 21332399 16723640 20518802 20132043 19632207 18674790 18457598 17217161 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
7.61 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
7.61 | 16049721 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.76 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
therapeutic |
|
| 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
CD 437 |
13.31 | 17474084 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
13.31 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
13.31 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
13.31 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
13.31 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
5.41 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.41 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
7.69 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
7.69 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
7.69 | 15976015 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.66 | 12065085 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
3.10 | 17218051 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.80 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.70 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.05 | 11550810 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.70 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.70 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.95 | 18007984 18929643 18381685 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.40 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.14 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.71 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
7.71 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.75 | 11118676 11896295 11399792 11222880 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.34 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.49 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
1.87 | 16289102 12479363 18247401 16644109 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.87 | 15749863 15897917 16888761 18437689 16729912 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.87 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
1.87 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.87 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.87 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.20 | 16636307 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
3.65 | 18058305 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.06 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.35 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
2.75 | 17620002 17894541 17720292 10334151 17266442 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.79 | 17922066 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
4.09 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
4.07 | 16303925 |
MESH:D012206 |
Rhabdomyolysis |
|
Lamivudine |
5.09 | 9296927 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.69 | 16283617 16116481 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.61 | 17203757 16767912 15625365 15675481 17710206 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.82 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.35 | 17846226 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
4.86 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
4.86 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.59 | 15451306 12880345 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
28.16 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
28.16 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
28.16 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Okadaic Acid |
28.16 | 12628509 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
28.16 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
28.16 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
28.16 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
28.16 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.13 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
3.84 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.60 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.45 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.17 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.17 | 17261132 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
3.17 | 17696246 |
MESH:D024801 |
Tauopathies |
|
Camptothecin |
5.18 | 16930453 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.45 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Butyrates |
14.40 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
14.40 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
14.40 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
14.40 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.23 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.40 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.95 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
21.22 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
21.22 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
CD 437 |
21.22 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
21.22 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
21.22 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
21.22 | 11723127 16452187 16712894 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
21.22 | 17572228 16712894 8653321 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
10.51 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
10.51 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.57 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
13.73 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
13.73 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
13.73 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.16 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.53 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
4.33 | 12579204 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.98 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.14 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.79 | 16364871 17334414 17678736 17638931 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.64 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.80 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.37 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.59 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.99 | 17120751 |